With ongoing advancements in diagnostics, we are continuing our coverage of key trends and news in the space. Guidepoint Insights help you learn more about new technologies and companies making headlines recently.

Trending topics being covered include (select calls of interest): 


    Liquid Biopsy Tests

    • Outlook on the use of liquid biopsies in early detection and asymptomatic screenings

    • What obstacles could possibly affect the broader adoption of liquid biopsy?

    • How business models are evolving for liquid biopsy technology


    • How is GRAIL technology best applied with regard to early detection, diagnostics, and residual disease monitoring?

    • Key features of GRAIL's Galleri, DAC, and other similar or related tests, and the moats around these diagnostics

    • Overview of competitors

    Nano-X Imaging

    • Overview of the business model for Nano-X Imaging, which features a low-cost device and a subscription or pay-per-scan arrangement

    • What types of X-ray images are best suited for Nano-X Imaging's technology, and what are potential applications for its cloud and AI initiatives?

    • Potential hurdles might Nano-X Imaging encounter in the regulatory process


    Please note:
    By clicking the ‘submit’ button you agree not to publish, share or otherwise disclose any information obtained to any third party without Guidepoint’s prior written consent. Limit of three transcript or teleconference requests per non-client organization within a six month period. Attendance is limited for all live teleconferences, and submission of interest does not guarantee a spot will be available for any particular event.